- Home
- NSSC vs MDXG Comparison
NSSC vs MDXG Comparison
Compare NSSC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- MDXG
- Stock Information
- Founded
- NSSC 1969
- MDXG 2006
- Country
- NSSC United States
- MDXG United States
- Employees
- NSSC N/A
- MDXG N/A
- Industry
- NSSC Telecommunications Equipment
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- NSSC Telecommunications
- MDXG Health Care
- Exchange
- NSSC Nasdaq
- MDXG Nasdaq
- Market Cap
- NSSC 899.1M
- MDXG 1.0B
- IPO Year
- NSSC N/A
- MDXG N/A
- Fundamental
- Price
- NSSC $26.37
- MDXG $7.05
- Analyst Decision
- NSSC Strong Buy
- MDXG Strong Buy
- Analyst Count
- NSSC 5
- MDXG 3
- Target Price
- NSSC $36.00
- MDXG $12.00
- AVG Volume (30 Days)
- NSSC 466.1K
- MDXG 812.0K
- Earning Date
- NSSC 05-05-2025
- MDXG 04-30-2025
- Dividend Yield
- NSSC 2.13%
- MDXG N/A
- EPS Growth
- NSSC N/A
- MDXG N/A
- EPS
- NSSC 1.22
- MDXG 0.27
- Revenue
- NSSC $181,227,000.00
- MDXG $352,375,000.00
- Revenue This Year
- NSSC N/A
- MDXG $9.23
- Revenue Next Year
- NSSC $7.11
- MDXG $11.49
- P/E Ratio
- NSSC $21.57
- MDXG $26.15
- Revenue Growth
- NSSC N/A
- MDXG 5.34
- 52 Week Low
- NSSC $19.00
- MDXG $5.47
- 52 Week High
- NSSC $58.09
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- NSSC 74.46
- MDXG 51.34
- Support Level
- NSSC $24.13
- MDXG $6.53
- Resistance Level
- NSSC $27.74
- MDXG $7.07
- Average True Range (ATR)
- NSSC 0.88
- MDXG 0.33
- MACD
- NSSC 0.52
- MDXG 0.10
- Stochastic Oscillator
- NSSC 78.56
- MDXG 68.03
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.